The other almost-certain win would be half-doses of the mRNA vaccines (ie, double supply) given the antibody responses we saw with lower doses, but that's proba

The other almost-certain win would be half-doses of the mRNA vaccines (ie, double supply) given the antibody responses we saw with lower doses, but that's probably asking for too much...